While there are examples of B.C. biotech companies that are struggling, that situation is not uniform sector-wide. Vancouver drug-maker AbCellera Biologics Inc. has seen its share price fall by ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

Release Jan 10 - Barinthus Bio: In a shift to focus on immunology and inflammation indications, the biotech is halting further development of VTP-300 for chronic hepatitis B viral infection and ...

The first Cohort B patient in Phase 2B trial for TCB008 in AML has completed full dosing and is expected to receive a fifth dose. Preliminary data from the trial show no drug-related adverse ...

The bioscience industry employed 6,666 people across 802 business establishments in New Mexico in 2023, according to a recent report released by Biotechnology Innovation, the Council of State ...

Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ... She pointed to the acquisition of Boston-based cancer-focused biotech IDRx last month as “a good ...

But local biotech leaders see signs of change in 2025. Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...